Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
850.00    34.00 (4.17%)
Bid:
844.00
Ask:
852.00
Spread: 8.00 (0.948%)
Market Cap: £391.82m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Acquisition of Seal

9 Jul 2008 07:00

RNS Number : 6172Y
Porvair PLC
09 July 2008
 



For immediate release 9 July 2008

Porvair plc 

("Porvair" or the "Group")

Acquisition of Seal Analytical Ltd

Porvair plc today announces the acquisition of Seal Analytical Ltd ("Seal"), a leading manufacturer of water quality analysis equipment for environmental and industrial laboratories. The acquisition allows Porvair to build on its position in water quality markets and brings immediate opportunities for cost savings and revenue growth.

Seal is being acquired from its shareholders who include The South East Growth Fund and Tim Brittain, Seal's Managing Director.

The acquisition values Seal's ordinary and preference share capital at up to £3.8 million (net of option receipts), to be settled by up to £2.3 million of cash and up to £1.5 million of shares in Porvair (the "Consideration Shares"). Porvair will also assume £2.2 million of Seal's existing bank borrowings and £0.3 million of finance leases for a total consideration of a maximum of £6.3 million pending net asset adjustments of up to £0.5 million. Seal had gross assets of £3.9 million at 30 June 2007, including goodwill of £1.2 million.

For the financial year ended 30 June 2008, Seal is expected to report revenues of approximately £7.6 million (2007: £6.0 million) and PBT of approximately £0.5 million (2007: loss of £0.7 million).

Seal's main products, analysis instruments and related consumables are highly regarded. Its seawater testing systems are the industry standard and it has grown its US business to be the market leader in the past four years. Seal is based in the UK and has larger operations in the USA and Germany. Around 15% of sales revenues are to UK customers. Key management will remain with the business following the acquisition. 

The global water quality equipment market is growing stronglyWater testing is generally mandatory and must be done using approved methods to which Seal's products conform. Independent estimates predict market growth of 11% per annum in the period 2008 - 2011 as water quality standards tighten across the world and laboratories automate their processes to achieve more consistent results. Seal has a good position in the well defined 'wet chemistry' segment of the market, which is concerned with the detection of inorganic contaminants in water.

Porvair already supplies this market with laboratory consumables, porous plastics and water filters and these existing activities will benefit from the strength of Seal's customer relationships. The board has also identified cost and operational benefits in the transaction and plans to expand Seal's product offering and geographic reach by using the wider scope of the Group. 

The acquisition is expected to be earnings enhancing in the first full year of ownership

Application will be made to the UK Listing Authority and the London Stock Exchange for the Consideration Shares to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange.

Commenting on the transaction, Ben Stocks, Chief executive of Porvair said:

"For some time we have been looking at ways of expanding our presence in water quality, a field closely related to the filtration we already do. Water quality concerns are growing around the world, driven by population growth, water scarcity and pollutionIn response, governments are expanding water quality standards, mandating testing by approved methods. The combined Porvair and Seal businesses are ideally placed to serve this growing requirement for domestic and commercial clean water analysis. We are excited by the business opportunities that this acquisition presents and we are pleased to welcome Seal's management and staff to the Porvair group."

For further information please contact:

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Altium

Nick Tulloch

Paul Chamberlain

Buchanan Communications

020 7484 4040

020 7466 5000

Charles Ryland / Ben Willey / Susanna Gale

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQRPMATMMAMBRP
Date   Source Headline
22nd May 20269:16 amRNSHolding(s) in Company
22nd May 20269:15 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSAppointment of Joint Corporate Broker
24th Apr 20264:30 pmRNSHolding(s) in Company
24th Apr 202610:15 amRNSHolding(s) in Company
14th Apr 20264:29 pmRNSResults of AGM
14th Apr 20267:00 amRNSAGM Trading Update
1st Apr 20264:30 pmRNSTotal Voting Rights
26th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSNotice of AGM
11th Mar 20267:00 amRNSNotice of AGM
3rd Mar 202610:00 amRNSHolding(s) in Company
27th Feb 20263:00 pmRNSTotal Voting Rights
24th Feb 20265:45 pmRNSDirector/PDMR Shareholding
19th Feb 20261:00 pmRNSHolding(s) in Company
17th Feb 20262:00 pmRNSDirector/PDMR Shareholding
13th Feb 20264:15 pmRNSDirector/PDMR Shareholding
9th Feb 20263:45 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSFull Year Results
6th Feb 20264:00 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
30th Jan 202612:00 pmRNSTotal Voting Rights
26th Jan 202610:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSAcquisition of Drache Umwelttechnik GmbH
6th Jan 20267:00 amRNSBlock listing Return
17th Dec 202510:00 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSYear end trading update and notice of results
11th Dec 20254:00 pmRNSHolding(s) in Company
5th Dec 20259:30 amRNSHolding(s) in Company
2nd Dec 202511:00 amRNSHolding(s) in Company
27th Oct 20257:00 amRNSTotal Voting Rights
7th Oct 20257:00 amRNSBlock Listing Return
25th Sep 20257:00 amRNSBoard Changes
16th Sep 20257:00 amRNSNine Month Trading Update
4th Sep 20257:30 amRNSHolding(s) in Company
23rd Jul 20255:30 pmRNSHolding(s) in Company
23rd Jul 20259:00 amRNSHolding(s) in Company
30th Jun 20257:00 amRNSInterim Results
19th Jun 202510:04 amRNSBlocklisting Application
17th Jun 20254:40 pmRNSHolding(s) in Company
29th May 202512:00 pmRNSHolding(s) in Company
28th Apr 20259:00 amRNSHolding(s) in Company
25th Apr 20259:00 amRNSHolding(s) in Company
17th Apr 20257:00 amRNSChange of Remuneration Committee Chair
15th Apr 20253:00 pmRNSHolding(s) in Company
15th Apr 20252:43 pmRNSAGM resolutions
15th Apr 20257:00 amRNSAGM Trading Update
9th Apr 202512:00 pmRNSBlock listing Interim Review
7th Apr 20258:00 amRNSDirector Declaration
4th Apr 202510:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.